Compare two stocks side-by-side:

Tidal Trust II MRNY | NASDAQ

$4.98 $0.00 | 0.00%
Market Cap: $42.29 M
PE Ratio:
52-Week Range: $4.719 - $26
1.2-year Total Return: -53.5%
Dividend Yield (FWD): 53.59%

Moderna, Inc. MRNA | NASDAQ

$39.39 -$0.17 | -0.43%
Market Cap: $15.16 B
PE Ratio: -6.78
52-Week Range: $35.8 - $170.47
1.2-year Total Return: -49.9%
Dividend Yield (FWD): 0.00%

1.2-year Total Returns with DRIP & Price Chart for MRNY and MRNA

1Y 2Y 5Y 10Y All
DRIPCalc.com
MRNY vs MRNA Returns

1.2-year Performance: Total Return (with DRIP), Diviendeds & Portfolio Value:

MRNY MRNA
Initial Balance $10,000 $10,000
Initial Price $20 $78.64
Initial Shares 500 127.16
 
Total Dividends $6,141 $0
Last Dividend $0.2224 $0
Estimated Divs $208 / month $0 / quarter
Yield-on-Cost 13.34% 0%
End Shares 933.3 (+433.3) 127.16
Last Shares Price $4.98 $39.39
Total End Value $4,648 $5,009
Total Return -53.5% -49.9%
Comparison start date: Oct 22, 2023

Dividend Payments & Dividend Yield Curve

Dividend Payments & Yield - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Dividend Payments & Yield - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A

DRIPCalc PRO - Compare is a dividend stocks research & comparison tool, where you can see side-by-side and visually compare:

Dividend payments & dividend yield curve, earnigns, cash, debt and differnt ratios for 1000s of stocks.

In demo-mode, you can see and compare all reports and charts for AAPL and MSFT stocks. Other stocks are availabe for members of DRIPCalc PRO.

When you sign up for DRIPCalc PRO for just $15/mo and 2 weeks Free Trial with full access, you will be able to compare and research any stock or ETF in our vast database!

Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Dividend Safety: Payout & Dividend to Free Cash Flow Ratios

Dividend Payout Ratio - MRNY
14-Day FREE Trial Get Full Access Now!
Dividend Payout Ratio - MRNA
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow (FCF) Ratio - MRNY
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow (FCF) Ratio - MRNA
14-Day FREE Trial Get Full Access Now!

Price charts for MRNY and MRNA.

Share Price - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Price CAGR:1Y: -76.58%2Y: -50.10%5Y: -24.27%10Y: -12.98%
Share Price - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Price CAGR:1Y: -54.30%2Y: -55.75%5Y: 14.71%10Y: 7.79%

Earnings, Revenue, Net Income, Dividends, Cash & Debt, Shares Outstaning, and other charts:

EPS vs PE Ratio - MRNY
14-Day FREE Trial Get Full Access Now!
EPS vs PE Ratio - MRNA
14-Day FREE Trial Get Full Access Now!
FCF vs FCF/Share - MRNY
14-Day FREE Trial Get Full Access Now!
FCF vs FCF/Share - MRNA
14-Day FREE Trial Get Full Access Now!
EPS vs FCF per Share - MRNY
14-Day FREE Trial Get Full Access Now!
EPS vs FCF per Share - MRNA
14-Day FREE Trial Get Full Access Now!
FCF vs Stock Based Comp - MRNY
14-Day FREE Trial Get Full Access Now!
FCF vs Stock Based Comp - MRNA
14-Day FREE Trial Get Full Access Now!
Revenue vs Net Income - MRNY
14-Day FREE Trial Get Full Access Now!
Revenue vs Net Income - MRNA
14-Day FREE Trial Get Full Access Now!
Cash & Debt - MRNY
14-Day FREE Trial Get Full Access Now!
Cash & Debt - MRNA
14-Day FREE Trial Get Full Access Now!
Revenue - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Revenue CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Revenue - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Revenue CAGR:1Y: 1.31%2Y: -24.10%5Y: 168.32%10Y: N/A
Earnings Per Share (EPS) - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY EPS CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Earnings Per Share (EPS) - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA EPS CAGR:1Y: 100.34%2Y: -88.65%5Y: 15.86%10Y: N/A
Net Income - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Net Income CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Net Income - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Net Income CAGR:1Y: 100.36%2Y: -88.84%5Y: 16.06%10Y: N/A
EBITDA - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY EBITDA CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
EBITDA - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA EBITDA CAGR:1Y: 104.48%2Y: -75.74%5Y: 21.88%10Y: N/A
Free Cash Flow - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Free Cash Flow CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Free Cash Flow - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Free Cash Flow CAGR:1Y: -1.32%2Y: N/A5Y: 72.09%10Y: N/A
Free Cash Flow / Share - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Free Cash Flow / Share CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Free Cash Flow / Share - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Free Cash Flow / Share CAGR:1Y: -2.35%2Y: N/A5Y: 66.94%10Y: N/A
Stock-Based Comp - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Stock-Based Comp CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Stock-Based Comp - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Stock-Based Comp CAGR:1Y: 45.45%2Y: 26.49%5Y: 40.03%10Y: N/A
Expenses - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Expenses CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Expenses - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Expenses CAGR:1Y: -0.92%2Y: 19.04%5Y: 52.80%10Y: N/A
Dividends - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Dividends - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Shares Outstanding - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Shares Outstanding CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Shares Outstanding - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Shares Outstanding CAGR:1Y: 4.72%2Y: -1.59%5Y: 3.82%10Y: N/A

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

REVENUE: Actual + Estimates - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Actual Revenue CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
REVENUE: Actual + Estimates - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Actual Revenue CAGR:1Y: 1.31%2Y: -24.10%5Y: 168.32%10Y: N/A
EPS: Actual + Estimates - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Actual EPS CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
EPS: Actual + Estimates - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Actual EPS CAGR:1Y: 100.34%2Y: -88.65%5Y: 15.86%10Y: N/A
NET INCOME: Actual + Estimates - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Actual Net Income CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
NET INCOME: Actual + Estimates - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Actual Net Income CAGR:1Y: 100.36%2Y: -88.84%5Y: 16.06%10Y: N/A
EBITDA: Actual + Estimates - MRNY
14-Day FREE Trial Get Full Access Now!
MRNY Actual EBITDA CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
EBITDA: Actual + Estimates - MRNA
14-Day FREE Trial Get Full Access Now!
MRNA Actual EBITDA CAGR:1Y: 104.48%2Y: -75.74%5Y: 21.88%10Y: N/A

Ratios, Profit Margins & Return on Capital:

Net Profit Margin - MRNY
14-Day FREE Trial Get Full Access Now!
Net Profit Margin CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Net Profit Margin - MRNA
14-Day FREE Trial Get Full Access Now!
Net Profit Margin CAGR:1Y: 100.35%2Y: -85.30%5Y: 14.88%10Y: N/A
Gross Profit Margin - MRNY
14-Day FREE Trial Get Full Access Now!
Gross Profit Margin CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Gross Profit Margin - MRNA
14-Day FREE Trial Get Full Access Now!
Gross Profit Margin CAGR:1Y: 422.87%2Y: 4.78%5Y: -6.28%10Y: N/A
Price to Earnings - MRNY
14-Day FREE Trial Get Full Access Now!
Price to Earnings - MRNA
14-Day FREE Trial Get Full Access Now!
Price To Sales Ratio - MRNY
14-Day FREE Trial Get Full Access Now!
Price To Sales Ratio - MRNA
14-Day FREE Trial Get Full Access Now!
Return on Capital Employed - MRNY
14-Day FREE Trial Get Full Access Now!
Return on Capital Employed - MRNA
14-Day FREE Trial Get Full Access Now!
Return on Invested Capital - MRNY
14-Day FREE Trial Get Full Access Now!
Return on Invested Capital - MRNA
14-Day FREE Trial Get Full Access Now!

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Values & Dividends for MRNY & MRNA

Based on past 1.2 years performance, MRNY had share price CAGR of -77.54%, and dividend CAGR of +0.00%.

During same period MRNA had share price CAGR of -56.79%, and dividend CAGR of +0.00%.

Using these CAGR metrics, we can estimate, that your initial $10,000 investment from 10 years ago, with dividends being reinvested (DRIP) should grow and collect dividends as follows:

MRNYMRNA
Start Value$10,000$10,000
Start Share Price$4.98$39.39
Start Shares2,008.03253.87
  
After 10 years:MRNYMRNA
Final Share Count29,120,049,312,538,968,883,987,340,961,975,557,802,226,183,590,203,152,756,101,711,039,053,361,577,984.00253.87
Dividends Payment$0.22$0.00
Annual Dividends$25,905,195,868,434,663,880,699,777,140,693,033,503,538,573,010,415,103,596,608,713,922,416,606,183,424$0
Share Price$0.00$0.02
Total Dividends$211,151,560,625,576,233,033,450,348,388,277,723,396,536,702,857,875,133,937,762,712,516,820,992$0
Final Value$211,151,560,625,576,257,553,379,002,242,499,457,130,089,137,262,822,071,837,588,667,454,455,808$5

Estimated Future Returns - MRNY
Estimated Future Returns - MRNA

Estimate Dividend Snowball and total future returns for MRNY and MRNA with our dividend (DRIP) calculator.

Above numbers are merely projections based on Dividend and Price CAGR for each stock, and should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these metrics.